1. Leung, Hoi Wing, Leung, Carmen Oi Ning, Lau, Eunice Y, Ma, Stephanie, Lee, Terence K. 2021. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma. In Cancer research, 81, 3229-3240. doi:10.1158/0008-5472.CAN-21-0184. https://pubmed.ncbi.nlm.nih.gov/33903122/
2. Ling, Junjun, Chang, Aoshuang, Zhao, Houyu, Ye, Huiping, Zhuo, Xianlu. 2022. EPHB2 as a recurrence-related gene and a prognostic indicator in nasopharyngeal carcinoma: A bioinformatics screening and immunohistochemistry verification. In Histology and histopathology, 37, 889-897. doi:10.14670/HH-18-459. https://pubmed.ncbi.nlm.nih.gov/35441696/
3. Zhang, Huazhi, Cui, Zhihui, Cheng, Du, Rong, Yueguang, Wang, Chenhui. 2020. RNF186 regulates EFNB1 (ephrin B1)-EPHB2-induced autophagy in the colonic epithelial cells for the maintenance of intestinal homeostasis. In Autophagy, 17, 3030-3047. doi:10.1080/15548627.2020.1851496. https://pubmed.ncbi.nlm.nih.gov/33280498/
4. Berrou, Eliane, Soukaseum, Christelle, Favier, Rémi, Nurden, Paquita, Bryckaert, Marijke. 2018. A mutation of the human EPHB2 gene leads to a major platelet functional defect. In Blood, 132, 2067-2077. doi:10.1182/blood-2018-04-845644. https://pubmed.ncbi.nlm.nih.gov/30213874/